

Changing the way we see the world
When Paul Emile Borduas published his groundbreaking manifesto back
in 1948, he did not realize that he was launching a movement that
would transform Quebec, Canada and even the world. In time, the
“Automatiste Revolution” would come to impact all artistic
disciplines, from painting to poetry, dance and theatre.
A
cross-border event
Having travelled the globe, “The Automatiste Revolution” is now
featured at the Albright-Knox Gallery in Buffalo. A special viewing
of the exhibition will take place for medical technology
entrepreneurs and innovators from the Buffalo area and the Greater
Toronto Area on Thursday, April 29, 2010.
An
opportunity to network with peers
In order to maximize the returns on your time, a visit to the
exhibition is being paired with a roundtable medical technology with
healthcare stakeholders in Ontario and the USA.
01:00
- 03:45 Roundtable on medical technologies,
4th
floor,
Buffalo Innovation Center, 640 Elllicot Street, Buffalo
(716-854-2662)
04:00 – 05:30 Reception & viewing, Albright-Knox
Gallery,
1285 Elmwood Ave, Buffalo (716-882-1958)
Please confirm your participation by phoning Marcel
at 095-888-1273 or emailing marcel@tmta.ca.

Is Brazil on your radar yet? If it isn’t, it should probably be.
As one of the world’s major emerging markets, its
economy is growing by leaps and bounds.
Its dual healthcare system (public & private) offers great
opportunities for growth.
And that system is ongoing a massive transformation.
To make things even easier for you, 40 Brazilian
healthcare professionals are heading our way.
They will be Toronto on October 26 and Ottawa October 27.
They’re eagerly looking to establish contacts with
Canadian medical technology entrepreneurs.
Presentations and site visits are being arranged in both cities.
The Toronto event takes place on October 26-27 and is
being coordinated by:
-
TMTA (the
Trillium Medical Technology Association),
-
the
Ontario Ministry of Health and
-
the
Federal Department of Foreign Affairs and International Trade.
The orientation session takes place on the 3rd
floor of the DFAIT office at 151 Yonge Street.
There is no charge for the meeting but your company
must register to be part of the event
and/or part of the related activities.
To register or to enquire about this opportunity,
phone Marcel at 095-888-1273 x331 or an email at marcel@tmta.ca.

Thanks to INO,
light technology
is now available
for a range of industry applications
Quebec-based INO (Institut national d'optique-
National Optics Institute) is Canada’s leading center of expertise
in industrial applications for optics/photonics. As the home of the
largest concentration of skills in the field, INO explores and
commercializes a variety of technologies and innovative processes.
As such, the firm serves clients of all sizes across Canada and
around the world.
INO's assets represent unique
business opportunities for companies looking for innovative
technologies to bring to the market place. These technology
transfers are carried out mainly through licensing or intellectual
property sales.
A key area of application for light
technologies involves the detection of listeria contamination, a
serious source for concern in the food industry. A solution in the
fight against this infection now comes to us from a Quebec-based
institute called INO (Institut national d'optique).
INO has just been selected by the Ontario Center of Excellence
(along with 4 other firms from a group of 20 candidates) to conduct
a feasibility study on various technologies to be used for to
identify the listeria bacterium. The INO project will specifically
focus on the Institute's optical cells reader platform
.
Depending on results, OCE will invest in finalizing a system
slightly different from the one INO has developed.
OCE may invest up to $200,000 per year for a 3 year period.
The money available through OCE is for the development of a fast
solution to Listeria
identification, but since the system to be developed involves a cell
reader, it will be possible to use this same reader for other
applications involving cells identification and counting by using
the appropriate assay.
One part of the project that has been accepted will involve the
development of a sensitive assay and it will be conducted by
Ms. Sue Chen from LabServices,
an INO partner in the project. Industry partners participating
in the project will be required to match OCE investments in cash and
in-kind contributions to the project. INO is actively looking for a
manufacturer that would like to participate in this project.
For the complete list of technologies available for
transfer, get in touch with TMTA by writing to marcel@tmta.ca
|